Manufactures commodity chemical intermediates, with core products being PAN and Maleic Anhydride. Holds approximately 50% share of India's PAN market and is the sole producer of Maleic Anhydride in India. A new Advance Plasticizer plant with 100,000 MT capacity was mechanically completed in March 2026, extending the product mix, and a Compressed Biogas (CBG) plant is targeted for completion by Q2 FY27. FY26 revenue was Rs 1,954 crores, down from Rs 2,234 crores in FY25, with EBITDA of Rs 130 crores at a 6.7% margin and PAT dropping to Rs 23.2 crores from Rs 112.5 crores. The Board recommended a dividend of Rs 5 per share. Raw materials account for 77.6% of revenue, making input prices the dominant cost driver. AR · MarketPing reader · 2026-08-02
Revenue streams, as the annual report describes them. Phthalic Anhydride (PAN), Maleic Anhydride, Plasticizers, Compressed Biogas (CBG). Cyclical, asset-heavy commodity chemicals producer with high raw-material cost exposure
| ₹ crore · consolidated | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | 1,883 | 2,352 | 2,099 | 2,206 | 1,925 |
| EBITDA (ex other income) | 407 | 318 | 105 | 219 | 95 |
| margin % | 21.6 | 13.5 | 5.0 | 9.9 | 4.9 |
| Owners' profit | 265 | 200 | 40 | 109 | 2 |
| EPS, as reported (₹) | 85.88 | 64.94 | 12.83 | 35.29 | 0.72 |
| ROE % · ROCE % | 24.9 · 29.3 | 16.2 · 19.5 | 3.2 · 5.3 | 8.1 · 11.1 | 0.2 · 3.1 |
| Debt / equity (x) | 0.15 | 0.20 | 0.29 | 0.20 | 0.27 |
| Cash from operations | 157 | 233 | 37 | 261 | 102 |
| Capex | (99) | (240) | (174) | (137) | (163) |
| ₹ crore | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 583 | 558 | 480 | 470 | 465 | 465 | 524 | 618 |
| Profit before tax | 34 | 36 | 25 | (16) | (1) | (13) | 40 | 90 |
| Net profit | 26 | 29 | 19 | (13) | (2) | (11) | 28 | 66 |
| EPS (₹) | 8.50 | 9.27 | 6.16 | (4.22) | (0.65) | (3.52) | 9.11 | 21.57 |
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % | Rev CAGR 5y % | EBITDA m. % |
|---|---|---|---|---|---|---|---|---|
| DEEPAK FERTILIZERS & PETR | 16,727 | 17.0 | 2.24 | 12.2 | 9.9 | 8.4 | 14.6 | 26.1 |
| TATA CHEMICALS LTD | 15,683 | — | 0.71 | 141.2 | (7.7) | (5.0) | 7.4 | 14.4 |
| GUJ NAR VAL FER & CHEM L | 8,273 | 8.0 | 0.91 | 6.0 | 8.9 | 10.3 | 8.7 | 22.1 |
| TANFAC INDUSTRIES LTD. | 6,773 | 55.4 | 18.15 | — | 18.8 | 24.3 | — | 16.0 |
| Date · filing | Category | Importance | 1-day % | 5-day % |
|---|---|---|---|---|
| 11 Aug 2026 · Earnings call transcript for Q1 FY26 filed with exchanges | investor communications | medium | — | — |
| 7 Aug 2026 · Audio link for Q1 FY26-27 earnings call posted on website | investor communications | low | — | — |
| 7 Aug 2026 · AGM results: All 6 resolutions passed, dividend declared | board shareholder meetings | low | — | — |
| 7 Aug 2026 · Strong Q1 FY27 results; EBITDA margin jumps to 19.2% | investor communications | medium | — | — |
| 6 Aug 2026 · 37th AGM held; all resolutions passed, e-voting results awaited | board shareholder meetings | medium | — | — |
| 6 Aug 2026 · Q1FY27 unaudited results published in newspapers | compliance | minimal | — | — |
| 5 Aug 2026 · Q1 FY27: Revenue up 31% YoY at Rs 618 cr; PAT swings to Rs 71 cr profit | results | high | — | — |
| 3 Aug 2026 · Earnings call scheduled for 7 August 2026 at 2:30 PM IST | board shareholder meetings | low | — | — |
| 31 Jul 2026 · Board Meeting on 5 Aug 2026 to consider Q1 FY27 results | results | low | — | — |
| 14 Jul 2026 · Routine quarterly dematerialisation compliance certificate filed | compliance | minimal | — | — |
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) | A state: the latest filed quarter and the measured reactions |
| GUJARAT ALKALIES & CHEM | 5,179 | 78.0 | 1.00 | 10.7 | (0.0) | 0.7 | 12.4 | 18.4 |
| GHCL LIMITED | 3,879 | 8.4 | 1.09 | 5.1 | 13.3 | 16.6 | 1.1 | 23.9 |
| GRAUER & WEIL IND LTD | 3,469 | 21.2 | 3.21 | 14.1 | 15.2 | 19.2 | 14.5 | 20.4 |
| J.G.CHEMICALS LIMITED | 2,330 | 31.0 | 4.31 | 23.7 | 12.7 | 16.9 | — | 11.5 |
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/E (TTM) | 20.7 | 17.0 | 35 of 57 | 39% |
| P/B | 1.3 | 1.4 | 28 of 59 | 53% |
| ROCE | 0.6 | 6.2 | 50 of 65 | 23% |
| ROE | 0.2 | 4.9 | 51 of 65 | 22% |
| Debt / Equity | 0.3 | 0.2 | 38 of 65 | 42% |
| EBITDA margin | 19.2 | 13.3 | 13 of 58 | 79% |
| Revenue growth | 31.4 | 6.7 | 12 of 54 | 79% |
| Profit growth | 611.6 | 21.0 | 6 of 64 | 92% |
| Market cap | 1692 | 77 | 10 of 65 | 86% |
| an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.
